AGF Management Ltd. Lowers Position in Danaher Corporation $DHR

AGF Management Ltd. trimmed its stake in Danaher Corporation (NYSE:DHR) by 22.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 8,359 shares of the conglomerate’s stock after selling 2,405 shares during the period. AGF Management Ltd.’s holdings in Danaher were worth $1,651,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in DHR. Red Tortoise LLC lifted its stake in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after acquiring an additional 98 shares in the last quarter. Ramirez Asset Management Inc. purchased a new stake in Danaher during the second quarter worth about $40,000. Costello Asset Management INC acquired a new stake in shares of Danaher during the first quarter worth about $41,000. Mowery & Schoenfeld Wealth Management LLC lifted its position in shares of Danaher by 53.8% during the first quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock worth $42,000 after purchasing an additional 71 shares in the last quarter. Finally, Strengthening Families & Communities LLC boosted its stake in shares of Danaher by 81.4% in the first quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock valued at $52,000 after purchasing an additional 114 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 2.2%

Danaher stock opened at $215.80 on Wednesday. The stock has a 50 day moving average of $204.36 and a two-hundred day moving average of $200.64. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The stock has a market capitalization of $152.43 billion, a price-to-earnings ratio of 44.49, a PEG ratio of 3.28 and a beta of 0.81. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the company posted $1.71 earnings per share. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is presently 26.39%.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on DHR shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a report on Wednesday, October 8th. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. JPMorgan Chase & Co. lifted their target price on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Wells Fargo & Company restated a “positive” rating on shares of Danaher in a report on Thursday, October 23rd. Finally, Redburn Partners set a $220.00 price target on Danaher in a research report on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.